Aileron Therapeutics, Inc. /
Lung Therapeutics, Inc.
Aileron Therapeutics completes Lung Therapeutics acquisition
What happened
Aileron Therapeutics, Inc. completed its acquisition of Lung Therapeutics, Inc. on October 31, 2023. The merger made Lung a wholly owned subsidiary of Aileron.
Aileron issued shares of common stock and newly designated Series X Preferred Stock to Lung stockholders and assumed Lung’s outstanding stock options and warrants.
The source
Everything on this page comes from the source below.
Aileron Therapeutics completes Lung Therapeutics acquisition
This document is the source for the companies, stage and people on this page.
Original filingUnlock with ProTimeline
Every date the source states, in order. Anything marked ahead is a target the source gives, not something that has happened.
Closed
The source this page is built from.
Published by the source
The source this page is built from.
The same firms, in other deals
The firms' deal history and connections across other deals.
These firms' full profiles are part of Pro.
Request accessAlready invited? Sign in
Carrywatch Pro is by invitation. An invite lets you buy Pro.
By email · Weekly